期刊文献+

禽流感病毒同义NP蛋白的原核表达及其间接ELISA检测方法的建立 被引量:3

Establishment of indirect ELISA method with consensus NP protein of avian influenza viruses as coated antigen
下载PDF
导出
摘要 为建立通用型禽流感病毒(AIV)快速检测方法,本研究将合成的同义NP(ConsNP)基因克隆于pET30a中,利用大肠杆菌系统进行原核表达,以纯化重组ConsN P蛋白作为包被抗原,建立了检测AIVNP抗体的间接ConsNP-ELISA方法,并优化了反应条件。结果表明:抗原包被量为1μg/孔;封闭剂为5%脱脂乳;一抗血清稀释度为1∶200;H RP标记的兔抗鸡IgG(酶标二抗)稀释度为1∶20 000;阴阳性临界值为:O D490nm值>0.239。该间接ELISA方法与其他亚型A IV阳性血清均呈阳性反应,与新城疫病毒,马力克病病毒,禽传染性囊病病毒阳性血清无交叉反应,具有良好的特异性和敏感性。本研究为进一步研制通用型的禽流感ConsN P-ELISA检测试剂盒奠定了基础。 To establish a rapid method for detection of antibody against avian influenza vires (AIV), the consensus NP gene of AIV was synthesized based on NP genes of H5 subtype AIV and cloned into pET30a for expressing in E.coli. The recombinant consensus NP protein was expressed and purified to be used as coated antigen for development of the indirect ConsNP-ELISA method. The working conditions of ConsNP-ELISA were optimized as follows: coating with 1 μg/well of the consensus NP at 4℃ ovemight, blocking with 5% of skimmed milk, incubating for 1 hour at 37 ℃, detecting at 1:200 dilution serum with the 1:20,000 dilution of second antibody of rabbit anti-chicken HRP-IgG. The cut-off value was 0.239. This established method was reacted positively with all subtypes of AWs, but no cross-reaction with positive serum of Newcastle disease virus, Marek's disease virus and infectious bursal disease virus, which possessed a high specificity and sensibility. This study provided a solid basis for the development of a universal ConsNP-ELISA kit for detection of antibody against AWs.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2013年第6期464-467,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家科技重大专项(2012ZX 10004214) 哈尔滨市科技攻关计划项目(2011A A 6BN 019)
关键词 禽流感病毒 同义NP蛋白 ELISA 检测 avian influenza virus consensus NP protein ELISA detection
  • 相关文献

参考文献7

  • 1Chen Hua-lan, Li Yan-bing, Li Ze-jun, et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China [J]. J Virol, 2006, 80(12): 5976-5983.
  • 2Gambotto A, Barratt-Boyes S M, et al. Human infection with highly pathogenic H5N1 influenza virus [J]. Lancet, 2008, 371(9622): 1464-1475.
  • 3于康震,崔尚金,付朝阳,唐秀英.禽流感与养禽业发展和人类健康[J].中国预防兽医学报,2000,22(4):312-315. 被引量:102
  • 4付朝阳,邢大昌,唐秀英,张亚非,于康震,冯菊艳.高致病力禽流感的流行与防制研究进展[J].中国预防兽医学报,2001,23(5):393-396. 被引量:30
  • 5Chen Qua-njiao, Kuang Hai-men, Wang Huadong, et al. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus [J]. Virue Genes, 2009, 38: 30-38.
  • 6Chen Ming-Wei, Cheng RT J, Huang Yao-xing, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses [J]. PANS, 2008, 105(36):13538-13543.
  • 7李海燕,辛晓光,田国斌,张晶,于康震.禽流感抗体斑点-ELISA诊断技术的研究[J].中国预防兽医学报,1999,21(5):321-324. 被引量:34

二级参考文献25

共引文献154

同被引文献26

  • 1黄庆华,张果平,王可.禽流感病毒NP蛋白单克隆抗体的研制和鉴定[J].江西农业学报,2010,22(12):141-143. 被引量:2
  • 2Bouvier N M, Palese P.The biology of influenza viruses [J].Viccine, 2008, 26: 49-53.
  • 3WHO Disease Outbreak News.Human infection with influenza A(H7N9) virus in China-update[EB/OL].http://www.who.int/csr/don/en/index.html, 2013-12-24.
  • 4Zhang Qian-yi, Shi Jian-zhong, Deng Guo-hua, et al.H7N9 influenza viruses are transmissible in ferrets by respiratory droplet [J].Science, 2013, 341(6144): 410-414.
  • 5Richard M, Schrauwen E J, de Graaf M, et al.Limited airborne transmission of H7N9 influenza A virus between ferrets [J].Nature, 2013, 501(7468): 560-563.
  • 6Watanabe T, Kiso M, Fukuyama S, et al.Characterization of H7N9 influenza A viruses isolated from humans [J].Nature, 2013, 501(7468): 551-555.
  • 7Zheng Li-yun, Wang Fu-yan, Yang Zhong-dong, et al.A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice [J].BMC Infect Dis, 2009, 9: 17-22.
  • 8Chen Ming-wei, Cheng T J R, Huang Yao-xing, et al.A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses [J].Proc Natl Acal Sci USA, 2008, 105(36): 13538-13543.
  • 9King J C, Cox M M, Reisinger K, et al.Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months [J].Vaccine, 2009, 27(47): 6589-6594.
  • 10Gomez L M M, Fenton M J.Immunobiology of influenza vaccines [J].Chest, 2013, 143(2): 502-510.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部